{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:24:36Z","timestamp":1792794276168,"version":"4.5.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"39","license":[{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Erasmus MC","id":[{"id":"https:\/\/ror.org\/018906e22","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001828","name":"Erasmus University Rotterdam","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001828","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009122","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009122","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Heart Foundation"},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>Lipoprotein(a) [Lp(a)] is a potential causal factor in the pathogenesis of aortic valve disease. However, the relationship of Lp(a) with new onset and progression of aortic valve calcium (AVC) has not been studied. The purpose of the study was to assess whether high serum levels of Lp(a) are associated with AVC incidence and progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A total of 922 individuals from the population-based Rotterdam Study (mean age 66.0\u00b14.2 years, 47.7% men), whose Lp(a) measurements were available, underwent non-enhanced cardiac computed tomography imaging at baseline and after a median follow-up of 14.0 [interquartile range (IQR) 13.9\u201314.2] years. New-onset AVC was defined as an AVC score &amp;gt;0 on the follow-up scan in the absence of AVC on the first scan. Progression was defined as the absolute difference in AVC score between the baseline and follow-up scan. Logistic and linear regression analyses were performed to evaluate the relationship of Lp(a) with baseline, new onset, and progression of AVC. All analyses were corrected for age, sex, body mass index, smoking, hypertension, dyslipidaemia, and creatinine. AVC progression was analysed conditional on baseline AVC score expressed as restricted cubic splines. Of the 702 individuals without AVC at baseline, 415 (59.1%) developed new-onset AVC on the follow-up scan. In those with baseline AVC, median annual progression was 13.5 (IQR = 5.2\u201337.8) Agatston units (AU). Lipoprotein(a) concentration was independently associated with baseline AVC [odds ratio (OR) 1.43 for each 50\u2005mg\/dL higher Lp(a); 95% confidence interval (CI) 1.15\u20131.79] and new-onset AVC (OR 1.30 for each 50\u2005mg\/dL higher Lp(a); 95% CI 1.02\u20131.65), but not with AVC progression (\u03b2: \u221271 AU for each 50\u2005mg\/dL higher Lp(a); 95% CI \u2212117; 35). Only baseline AVC score was significantly associated with AVC progression (P &amp;lt; 0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In the population-based Rotterdam Study, Lp(a) is robustly associated with baseline and new-onset AVC but not with AVC progression, suggesting that Lp(a)-lowering interventions may be most effective in pre-calcific stages of aortic valve disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehac377","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T07:08:34Z","timestamp":1658560114000},"page":"3960-3967","source":"Crossref","is-referenced-by-count":94,"title":["Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification"],"prefix":"10.1093","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6869-0042","authenticated-orcid":false,"given":"Yannick","family":"Kaiser","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands"},{"name":"Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam , Amsterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine E","family":"van der Toorn","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands"},{"name":"Department of Radiology & Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny S","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands"},{"name":"Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands"},{"name":"Department of Clinical Chemistry, Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang H","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam , Amsterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5976-6519","authenticated-orcid":false,"given":"Maryam","family":"Kavousi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J G","family":"Sijbrands","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9555-6260","authenticated-orcid":false,"given":"Erik S G","family":"Stroes","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam , Amsterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike W","family":"Vernooij","sequence":"additional","affiliation":[{"name":"Department of Radiology & Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda B","family":"de Rijke","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Matthijs","family":"Boekholdt","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam , Amsterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bos","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands"},{"name":"Department of Radiology & Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,23]]},"reference":[{"key":"2023011417263271900_ehac377-B1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/heartjnl-2012-302265","article-title":"The evolving epidemiology of valvular aortic stenosis. The Troms\u00f8 study","volume":"99","author":"Eveborn","year":"2013","journal-title":"Heart"},{"key":"2023011417263271900_ehac377-B2","doi-asserted-by":"crossref","first-page":"iv7","DOI":"10.1136\/heartjnl-2012-302395","article-title":"Degenerative calcific aortic stenosis: a natural history","volume":"98","author":"Iung","year":"2012","journal-title":"Heart"},{"key":"2023011417263271900_ehac377-B3","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1161\/ATVBAHA.116.308271","article-title":"Estimating the population impact of Lp(a) lowering on the incidence of myocardial infarction and aortic stenosis\u2014brief report","volume":"36","author":"Afshar","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023011417263271900_ehac377-B4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N Engl J Med"},{"key":"2023011417263271900_ehac377-B5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","article-title":"Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population","volume":"63","author":"Kamstrup","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2023011417263271900_ehac377-B6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCGENETICS.113.000400","article-title":"Lipoprotein(a) levels, genotype, and incident aortic valve stenosis a prospective Mendelian randomization study and replication in a case-control cohort","volume":"7","author":"Arsenault","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"2023011417263271900_ehac377-B7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"Lipoprotein(a) reduction in persons with cardiovascular disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N Engl J Med"},{"key":"2023011417263271900_ehac377-B8","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jcmg.2019.01.045","article-title":"Why and how to measure aortic valve calcification in patients with aortic stenosis","volume":"12","author":"Pawade","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023011417263271900_ehac377-B9","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1136\/heartjnl-2020-317125","article-title":"Computed tomography aortic valve calcium scoring for the assessment of aortic stenosis progression","volume":"106","author":"Doris","year":"2020","journal-title":"Heart"},{"key":"2023011417263271900_ehac377-B10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/01.ATV.0000255952.47980.c2","article-title":"Aortic valve calcification: determinants and progression in the population","volume":"27","author":"Messika-Zeitoun","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023011417263271900_ehac377-B11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/heartjnl-2021-319804","article-title":"Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis","volume":"108","author":"Kaiser","year":"2022","journal-title":"Heart"},{"key":"2023011417263271900_ehac377-B12","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.amjcard.2009.10.071","article-title":"Incidence and progression of aortic valve calcium in the multi-ethnic study of atherosclerosis (MESA)","volume":"105","author":"Owens","year":"2010","journal-title":"Am J Cardiol"},{"key":"2023011417263271900_ehac377-B13","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N Engl J Med"},{"key":"2023011417263271900_ehac377-B14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rosseb\u00f8","year":"2008","journal-title":"N Engl J Med"},{"key":"2023011417263271900_ehac377-B15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","article-title":"Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (astronomer) trial","volume":"121","author":"Chan","year":"2010","journal-title":"Circulation"},{"key":"2023011417263271900_ehac377-B16","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10654-017-0321-4","article-title":"The Rotterdam Study: 2018 update on objectives, design and main results","volume":"32","author":"Ikram","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"2023011417263271900_ehac377-B17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"2023011417263271900_ehac377-B18","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jacc.2019.01.070","article-title":"Lipoprotein(a) and oxidized phospholipids promote valve calcification in patients with aortic stenosis","volume":"73","author":"Zheng","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023011417263271900_ehac377-B19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41586-018-0198-8","article-title":"Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice","volume":"558","author":"Que","year":"2018","journal-title":"Nature"},{"key":"2023011417263271900_ehac377-B20","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJM200008313430903","article-title":"Predictors of outcome in severe, asymptomatic aortic stenosis","volume":"343","author":"Rosenhek","year":"2000","journal-title":"N Engl J Med"},{"key":"2023011417263271900_ehac377-B21","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jacc.2015.07.020","article-title":"Oxidized phospholipids, lipoprotein(a), and progression of calcific aortic valve stenosis","volume":"66","author":"Capoulade","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2023011417263271900_ehac377-B22","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1136\/heartjnl-2021-319044","article-title":"Lipoprotein(a) is robustly associated with aortic valve calcium","volume":"107","author":"Kaiser","year":"2021","journal-title":"Heart"},{"key":"2023011417263271900_ehac377-B23","first-page":"111","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"2020","author":"Mach","year":"2019","journal-title":"Eur Heart J"},{"key":"2023011417263271900_ehac377-B24","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/eurheartj\/ehr157","article-title":"Inter-scan variability of coronary artery calcium scoring assessed on 64-multidetector computed tomography vs. Dual-source computed tomography: a head-to-head comparison","volume":"32","author":"Ghadri","year":"2011","journal-title":"Eur Heart J"},{"key":"2023011417263271900_ehac377-B25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jama.2020.27205","article-title":"Prevalence of bicuspid aortic valve and associated aortopathy in newborns in Copenhagen, Denmark","volume":"325","author":"Sillesen","year":"2021","journal-title":"JAMA"},{"key":"2023011417263271900_ehac377-B26","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/01.ATV.16.12.1568","article-title":"Lipoprotein(a) in stored plasma samples and the ravages of time","volume":"16","author":"Kronenberg","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/39\/3960\/48713930\/ehac377.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/39\/3960\/48713930\/ehac377.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T12:27:08Z","timestamp":1673699228000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/39\/3960\/6649081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,23]]},"references-count":26,"journal-issue":{"issue":"39","published-online":{"date-parts":[[2022,7,23]]},"published-print":{"date-parts":[[2022,10,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehac377","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,14]]},"published":{"date-parts":[[2022,7,23]]}}}